In Puerto Rico, costs send pharma packing

Poor Puerto Rico. Pharmaceuticals firms are shutting down plants in the U.S. territory, eliminating some 3,000 jobs. Reasons for the closures include Big Pharma's worldwide restructuring, Puerto Rico's expiring tax breaks and high utility bills. Already, Teva Pharmaceuticals, GlaxoSmithKline, Schering-Plough, Watson Pharmaceuticals and Bristol-Myers Squibb have either shuttered facilities or announced plans to do so.

Local lawmakers could remedy the situation by offering new industrial tax breaks to replace an IRS provision that expired last year, but they've been unable to agree on a new approach.

- read this report for more

Related Article:
GSK plant closure begins 5,000 job cuts. Report

Suggested Articles

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

Bristol Myers Squibb's Zeposia will leverage promising top-line phase 3 data into a possible FDA approval in the lucrative ulcerative colitis market.